Is Biovaxys Technology Corp halal to invest in?

According to Musaffa's Shariah screening methodology, Biovaxys Technology Corp (BIOV.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Biovaxys Technology Corp a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biovaxys Technology Corp using these criteria to determine its compliance status.

Can Muslims buy shares of Biovaxys Technology Corp?

Muslim investors may consider investing in Biovaxys Technology Corp if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Biovaxys Technology Corp classified as NOT HALAL?

Musaffa determines the Shariah status of Biovaxys Technology Corp by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Biovaxys Technology Corp updated?

The Shariah compliance status of Biovaxys Technology Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Biovaxys Technology Corp become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Biovaxys Technology Corp?

You can check the latest Shariah compliance status of Biovaxys Technology Corp on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BIOV.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: July 15, 2025

Report Source: 2025 2nd Quarter Report

Biovaxys Technology Corp. Stock Analysis BIOV.CN

Canada N/A Nano Cap Report: Q2, 2025

BioVaxys Technology Corp. is a clinical stage biotechnology company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-11-21. The firm is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization for food allergies, and other immunological diseases. The firm's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. MVP-S delivers antigenic peptides from survivin, a well-recognized cancer antigen commonly overexpressed in advanced cancers and also delivers an innate immune activator and a universal CD4 T cell helper peptide.

Key Statistics of Biovaxys Technology Corp (BIOV.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.07CAD0.07

Today's Open

CAD0.07

Volume

13.47K

P/E Ratio (TTM)

52 Week Range

CAD0.03CAD4.00

Market Cap

1.75M

Avg. Volume

170.03K

Dividend Yield

Financial Metrics & Statements of Biovaxys Technology Corp (BIOV.CN)

FAQ's for Biovaxys Technology Corp (BIOV.CN)

According to Musaffa’s Shariah screening methodology, Biovaxys Technology Corp (BIOV.CN) is currently classified as NOT HALAL as of July 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.